Date | Title | Description | |
---|---|---|---|
26 Jul 2023 | On P&L | The Company releases the first half 2023 financial results presentation | Download |
26 Jul 2023 | On buy-back programmes | The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program. | Download |
10 May 2023 | On P&L | The Company releases the first quarter 2023 financial results presentation | Download |
10 May 2023 | On P&L | The Company releases the press release related to the first quarter 2023 financial results | Download |
25 Apr 2023 | On business and financial situation | ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) | Download |
Pages
Date | Title | Description | |
---|---|---|---|
21 May 2024 | Announcement of general shareholders’ meeting | Publication of the announcement of the call to the General Shareholders’ Meeting and the documentation related thereto. | Download |
17 May 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 10 May and 16 May 2024 | Download |
10 May 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 2 May and 9 May 2024 | Download |
08 May 2024 | Announcement of General Shareholders’ Meeting | The Company announces the decision of its Board of Directors to convene the Ordinary General Shareholders' Meeting | Download |
30 Apr 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 26 April and 30 April 2024 | Download |
Pages
Date | Title | Description | |
---|---|---|---|
09 Oct 2015 | Otros sobre operaciones corporativas | Download | |
08 Oct 2015 | Otros sobre operaciones corporativas | Download | |
30 Jul 2015 | Información sobre resultados (2) | Download | |
30 Jul 2015 | Información sobre resultados | Download | |
30 Jun 2015 | Información sobre dividendos | Download |